Evidence map›Paper›PMID 24672514›Full record

ArticleFrontiers in microbiology2014

Death by a thousand cuts: the challenges and diverse landscape of lignocellulosic hydrolysate inhibitors.

Jeff S Piotrowski, Yaoping Zhang, Donna M Bates, David H Keating, Trey K Sato, Irene M Ong, Robert Landick

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. UsingACS ES&T engineering · 2026
    Article
  3. Article
  4. Energetic and structural control of polyspecificity in a multidrug transporter.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Review
  7. An Evolved Strain of the Oleaginous YeastJournal of fungi (Basel, Switzerland) · 2023
    Article
  8. FromJournal of fungi (Basel, Switzerland) · 2023
    Review
  9. Advances inJournal of fungi (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jeff S PiotrowskiDOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison Madison, WI, USA.
Yaoping ZhangDOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison Madison, WI, USA.
Donna M BatesDOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison Madison, WI, USA.
David H KeatingDOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison Madison, WI, USA.
Trey K SatoDOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison Madison, WI, USA.
Irene M OngDOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison Madison, WI, USA.
Robert LandickDOE Great Lakes Bioenergy Research Center, University of Wisconsin-Madison Madison, WI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lignocellulosic hydrolysate (LCH) inhibitors are a large class of bioactive molecules that arise from pretreatment, hydrolysis, and fermentation of plant biomass. These diverse compounds reduce lignocellulosic biofuel yields by inhibiting cellular processes and diverting energy into cellular responses. LCH inhibitors present one of the most significant challenges to efficient biofuel production by microbes. Development of new strains that lessen the effects of LCH inhibitors is an economically favorable strategy relative to expensive detoxification methods that also can reduce sugar content in deconstructed biomass. Systems biology analyses and metabolic modeling combined with directed evolution and synthetic biology are successful strategies for biocatalyst development, and methods that leverage state-of-the-art tools are needed to overcome inhibitors more completely. This perspective considers the energetic costs of LCH inhibitors and technologies that can be used to overcome their drain on conversion efficiency. We suggest academic and commercial research groups could benefit by sharing data on LCH inhibitors and implementing "translational biofuel research."

Indexed as

cellulosic biofuelschemical genomicsethanologenslignocellulosic hydrolysate inhibitorsmetabolic modelingsystems biology

Identifiers

PMID24672514
PMCPMC3954026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.